Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Stocrin
Active Ingredient(s): Efavirenz 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Stocrin
Active Ingredient(s): Efavirenz 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).